USA - May 5 2016
Those working in the pharmaceutical space are used to hearing complaints about the high costs of drugs, and patents often are blamed for allowing…
USA - December 1 2014
Obtaining certified copies of patent applications can be essential to perfecting a priority claim. But when a U.S. priority application contains a…
USA - July 29 2016
This is the first update on CRISPR, following on from our June 24 web conference entitled, "Navigating the CRISPR Patent Landscape and Business…
Tianran Yan
USA - December 29 2015
Before his recent arrest, Martin Shkreli, the former CEO of Turing Pharmaceuticals, gained notoriety for increasing the price of the AIDS drug…
USA - July 29 2016
CRISPR is a gene editing technique that promises to revolutionize genetic engineering, but already is raising ethical, business, and legal issues…
Stephen B. Maebius, Tianran Yan